Clinical trial
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
NCT06060613
Study timeline
Study start (actual)2023-10-25Date precision: day
Registry last updated2026-10-05
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Tumor Skinunresolved
Metastatic Melanomaunresolved
Melanomaunresolved
Lung Cancerunresolved
Metastatic Lung Cancerunresolved
Non Small Cell Lung Cancerunresolved
Metastatic Non Small Cell Lung Cancerunresolved
Interventions
OBX-115BIOLOGICAL
Sponsors & collaborators
Obsidian Therapeutics, Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06060613 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.